Quantcast
Last updated on April 24, 2014 at 14:25 EDT

Latest InSightec Ltd. Stories

2012-10-11 07:27:49

TEL AVIV, Israel, October 11, 2012 /PRNewswire/ -- Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today that on October 10, 2012, Elbit Medical Technologies Ltd. ("Elbit Medical") (TASE: EMTC-M) (in which the Company holds approximately 90%), and InSightec Ltd. ("InSightec") (in which Elbit Medical holds approximately 64.3%, and 53% on a fully diluted basis), have entered into a share purchase agreement (the "Investment Agreement") with GE Healthcare...

2012-08-20 02:30:40

TIRAT CARMEL, Israel, August 20, 2012 /PRNewswire/ -- InSightec [http://www.insightec.com ] Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration (FDA) to begin a Phase I clinical trial evaluating the use of its ExAblate(R) Neuro [http://www.insightec.com/ExAblate-Neuro.html ] system for the treatment of patients with tremor dominant Parkinson's Disease. Thirty patients who suffer...

2012-02-27 02:44:00

TEL AVIV, Israel, February 27, 2012 /PRNewswire/ -- Elbit Imaging Ltd. (NASDAQ: EMITF) ("Elbit" "Company") announced that it's subsidiary, Elbit Medical Technologies Ltd. (TASE: ELMDT) ("EMT"), (in which the Company holds approximately 90% and approximately 93% on a fully diluted basis), announced today that InSightec Ltd. (in which the Company together with EMT holds approximately 66%) ("InSightec"), and InSightec's wholly owned subsidiary have entered into long term funding...

2012-01-24 03:00:00

TIRAT CARMEL, Israel, January 24, 2012 /PRNewswire/ -- InSightec Ltd, the leader in MR guided Focused Ultrasound therapy, announced that it has submitted a premarket approval application (PMA) to the U.S. Food and Drug Administration (FDA) for its ExAblate treatment of pain palliation of bone metastases. [http://www.bone-pain-palliation.co.uk ] ExAblate uses MR guided focused ultrasound (MRgFUS) to treat the pain caused by bone metastases non-invasively and without ionizing...

2012-01-03 03:30:00

TIRAT CARMEL, Israel, January 3, 2012 /PRNewswire/ -- InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS) therapy, announced today that it has completed enrollment in the world's first feasibility study [http://www.clinicaltrials.gov/ct2/show/NCT01304758?term=ExAblate&rank=4 ] evaluating the use of MRgFUS for treatment of Essential [http://www.insightec.com/Essential_Tremor.html ] Tremor, using ExAblate(R) Neuro at University of Virginia...

2011-11-27 03:00:00

TIRAT CARMEL, Israel, November 27, 2011 /PRNewswire/ -- InSightec Ltd announced that NICE, the National Institute for Health and Clinical Excellence of the NHS in the UK, announced new favorable guidelines for the treatment of uterine fibroids using MR guided Focused Ultrasound. The new guidelines state that the current evidence on the efficacy of magnetic resonance image (MRI)-guided transcutaneous focused ultrasound treatment for uterine fibroids and evidence on safety are...

2011-09-21 02:00:00

TIRAT CARMEL, Israel, September 21, 2011 /PRNewswire/ -- InSightec Ltd., the global leader in MR guided Focused Ultrasound (MRgFUS) technology, announced today that its investigational ExAblate(R) Neuro system has been used in clinical studies to treat 30 patients suffering from chronic neurological disorders. The clinical trials are being conducted by functional neurosurgeons, neurologists and neuroradiologists in Switzerland, and the US to evaluate the safety and initial...

2011-07-13 08:00:00

TIRAT CARMEL, Israel, July 13, 2011 /PRNewswire/ -- Initial Results are Encouraging, Spurring Hope for a Treatment Option With a Lower Rate of Complications InSightec Ltd., the global leader in MR-guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that 23 patients with organ confined low risk prostate cancer have already been treated with its ExAblate(R) system in...

2010-11-25 02:01:00

TEL AVIV, Israel, November 25, 2010 /PRNewswire-FirstCall/ -- Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit") announced today that, further to its announcement dated September 13, 2010, it has successfully closed the transaction with Enter Holdings 1 Ltd. (TASE: ENHD) ("Enter") and Enter's controlling shareholders, resulting in the issuance of Enter shares representing a 90% interest in Enter and the grant of exercise-price free options exercisable into shares of Enter, which together...

2010-09-29 01:58:00

TIRAT CARMEL, Israel, September 29, 2010 /PRNewswire/ -- InSightec Ltd., the global leader in MR guided Focused Ultrasound technology (MRgFUS) announced today that it will be launching ExAblate(R) One for the treatment of uterine fibroids, adenomyosis and research options in women's health and the ExAblate(R) OR system as the Operating Room of the future at the upcoming Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2010 meeting. (Logo:...